DENKA MARAH: Open Payments
NPI 1669916961 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,854 in 129 payments from 11 companies in 2025. Trend: 2023 $3,372 · 2024 $2,685 · 2025 $2,854
Food & beverage: $2,854
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 38 | $1,055 |
| Gilead Sciences, Inc. | 32 | $656 |
| ABBVIE INC. | 24 | $421 |
| Otsuka America Pharmaceutical, Inc. | 9 | $199 |
| Theratechnologies Inc. | 10 | $176 |
| Napo Pharmaceuticals Inc | 5 | $103 |
| Teva Pharmaceuticals USA, Inc. | 4 | $81 |
| Merck Sharp & Dohme LLC | 3 | $66 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $62 |
| Alkermes, Inc. | 1 | $18 |
Products named: DOVATO, VRAYLAR, RUKOBIA, REXULTI, EGRIFTA, APRETUDE, Mytesi, CABENUVA.
Industry payments across PA — which companies pay providers there.
